Merck Life Science A/S: Financial statements 2013
CVR: 20830131
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 25,961,931 and a net result of DKK 4,236,623 compared with DKK 4,273,000 the year before. That is an increase of 51.5% compared with the year before. Equity in the 2013 report amounted to DKK 24,212,158. The solvency ratio was 63.4%.
- Gross Profit
- DKK 25,961,931
- Profit/Loss
- DKK 4,236,623
- Equity
- DKK 24,212,158
- Total Assets
- DKK 38,178,712
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | 26M | 4.2M | 24.2M | - |
| 2012 | 25.8M | 17.1M | 4.3M | 20M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
Merck Life Science A/S has published its annual report for 2012. Revenue came to DKK 25,846,000, and the net result was DKK 4,273,000.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.